Glaxosmithkline Pharmaceuticals fundamental analysis
GLAXO
2372.1
26.60 (-1.11%)Last updated on 9 Jan, 2026 | 15:57 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
42.11
P/B Ratio
23.56
Div. Yield
2.27
Sector P/E
69.98
Sector P/B
0.95
Sec. Div. Yield
0.57
Glaxosmithkline Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 42.11, compared to the sector average of 69.98. Its P/B Ratio stands at 23.56, while the sector’s is 0.95. In terms of returns, the stock offers a Dividend Yield of 2.27%, which is than the sector’s 0.57%.
Glaxosmithkline Pharmaceuticals Score Card
Price
Attractive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Glaxosmithkline Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
